Evidence map›Paper›PMID 33156757›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2020

The effect of TB treatment on health-related quality of life for people with advanced HIV.

V Opollo, X Sun, R Lando, S Miyahara, T S Torres, M C Hosseinipour, G P Bisson, J Kumwenda, A Gupta, M Nyirenda and 4 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 6 countries.

V OpolloKenya Medical Research Institute, HIV-Research Branch, Kisumu, Kenya.
X SunHarvard T. H. Chan School of Public Health, Boston, MA, USA.
R LandoKenya Medical Research Institute, HIV-Research Branch, Kisumu, Kenya.
S MiyaharaHarvard T. H. Chan School of Public Health, Boston, MA, USA.
T S TorresInstituto Nacional de Infectologia Evandro Chagas (INI-FIOCRUZ), Rio de Janeiro, RJ, Brazil.
M C HosseinipourUniversity of North Carolina School of Medicine, Chapel Hill, NC, USA, University of North Carolina Project, Lilongwe, Malawi.
G P BissonPerlman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
J KumwendaJohns Hopkins Project, Blantyre, Malawi.
A GuptaJohns Hopkins University School of Medicine, Baltimore, MD, USA.
M NyirendaJohns Hopkins Project, Blantyre, Malawi.
K KatendeJoint Clinical Research Centre Clinical Research Site, Kampala, Uganda.
N SuryavanshiByramjee Jeejeebhoy Government Medical College Clinical Trials Unit, Pune, India.
F BeulahYR Gaitonde Centre for AIDS Research and Education, Chennai Antiviral Research and Treatment Clinical Research Site, Chennai, India.
N S ShahCenters for Disease Control and Prevention, Atlanta, GA, USA.
Blantyre Institute for Community Ophthalmology · MWHarvard University · USKenya Medical Research Institute · KECenters for Disease Control and Prevention · USGovernment Medical College · INInstituto Evandro Chagas · BRJohns Hopkins University · USJoint Clinical Research Centre · UGUniversity of Pennsylvania · USYR Gaitonde Centre for AIDS Research and Education · IN

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)UM1AI068634 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Marlene Ann Cooper, Michael David Hughes · 2011 to 2026
$246.6M
Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trialsUM1AI106701 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$116.8M
The Malawi Clinical Trials UnitUM1AI069518 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACKY M JENNINGS, TAHA E TAHA · 2012 to 2026
$43.8M
Units for HIV/AIDS Clinical Trials NetworksU01AI069463 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI SANNE, IAN MATTHIAS · 2007 to 2011
$24.2M
NIAID NIH HHS UM1 AI068634NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069518NIAID NIH HHS UM1 AI106701PEPFAR
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV InfectionsTuberculosisAgedAntitubercular AgentsHumansIsoniazidQuality of LifeAntitubercular AgentsIsoniazid

Identifiers

PMID33156757
PMCPMC8378247
OpenAlexW3092248676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.